Acupuncture for Hypertension: Systematic Review Evidence and Physiological Mechanisms

Acupuncture demonstrates modest but reproducible blood pressure (BP) reduction in hypertension, suitable as adjunctive therapy—not monotherapy replacement.

Evidence Summary

• Meta-analyses (2017–2021): 20+ RCTs; acupuncture reduces SBP 5–10 mmHg, DBP 3–6 mmHg vs. sham/waitlist. Greater effect in stage 1–2 HTN, treatment-naive, or medication-intolerant.
• RCTs (2018–2019): Acupuncture + lifestyle > lifestyle alone; reduced medication burden in some.
• Limitations: Heterogeneity, sham credibility, small samples, short follow-up.

Proposed Mechanisms

• Sympathetic inhibition: ↓ Norepinephrine, renin-angiotensin-aldosterone activity via hypothalamic/medullary centers.
• Vagal activation: ↑ Baroreflex sensitivity, HR variability.
• Endothelial function: ↑ NO bioavailability, ↓ endothelin-1 → vasodilation.
• Endogenous opioids: β-endorphin, enkephalins mediate central cardiovascular regulation.
• Local effects: Segmental vasodilation at needle sites (calcitonin gene-related peptide).

Clinical Protocol

• Points: LI4, LI11, ST36, SP6, LR3, GB20, HT7, PC6, GV20, EX-HN1 (Sishencong)
• Electroacupuncture: 2 Hz, 20–30 min, 2–3×/week × 8–12 weeks
• Maintenance: weekly → biweekly → monthly

Critical Caveats

• Never stop antihypertensives without physician guidance.
• Monitor home BP daily; share logs with prescriber.
• Not for hypertensive urgency/emergency (SBP >180 or DBP >120 with end-organ threat).
• Contraindicated: bleeding disorders, anticoagulants (caution), pacemaker (electro), pregnancy (avoid LI4, SP6, GB21, CV3–7).

Acupuncture is a validated adjunct for BP management. Integrate with lifestyle (DASH, sodium <1500mg, exercise, weight loss, stress reduction) and pharmacotherapy per JNC/ACC/AHA guidelines.